Showing results (2261-2270 of 4,223) with videos related to

Sort By:
Pageof 423
Discover Oncology|November 15, 2024
Survival prediction in patients with head and neck squamous cell carcinoma and novel mechanistic insights of S100A8/A9Yihong Hu, Minhui He, Yucheng Han, et al.
Discover Oncology|November 15, 2024
The potential of kaempferol in digestive system tumors: recent advances and mechanistic insightsXunxing Hao, Meng Ding, Chenyu Chi, et al.
Discover Oncology|November 18, 2024
ATP6V1C1, associated with the tumor microenvironment and mTORC1 signaling pathway, is a potential diagnostic, prognostic, and therapeutic biomarker for hepatocellular carcinomaYuhao Pan, Hao Chen, Chenhui Lv, et al.
Discover Oncology|November 15, 2024
Network pharmacology and in vitro experiments to investigate the anti-gastric cancer effects of paeoniflorin through the RAS/MAPK signaling pathwayYating Yang, Ling Yuan, Yuhua Du, et al.
Discover Oncology|November 15, 2024
Immune-oncology targets and therapeutic response of cell pyroptosis-related genes with prognostic implications in neuroblastomaXingyu Liu, Zhongya Xu, Hanjun Yin, et al.
Discover Oncology|November 9, 2024
Hsa_circ_0000423 promotes colorectal cancer EMT and immune escape by competitive adsorption of miR-369-3p mediating CCND1 expressionTianFu Huang, KaiHai Jiang, LinTao Li, et al.
Discover Oncology|November 8, 2024
Advances and prospects in tumor infiltrating lymphocyte therapyXu Qiu, Shengjun Li, Tianyu Fan, et al.
Discover Oncology|November 9, 2024
Development of a novel disulfidptosis-correlated m6A/m1A/m5C/m7G gene signature to predict prognosis and therapeutic response for lung adenocarcinoma patients by integrated machine-learningBilin Xu, Liangyu Zhang, Lijie Lin, et al.
Discover Oncology|October 8, 2024
Effectiveness of radiotherapy in delaying treatment changes in primary or secondary immunorefractory oligoprogressive patients: preliminary results from a single-center studyValentina Zagardo, Emanuele Martorana, Mandara Harikar, et al.
Discover Oncology|November 2, 2024
The causal relationship between anti-CD20 antibodies and endometrial cancer: a Mendelian randomization studyJinqiu Su, Zhuang Li, Jianli Wang, et al.
Pageof 423